FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

María José Safont

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
María José Safont; Elena Sanmartín; Rafael Sirera; Cristina Caballero; Nieves Del Pozo; Sandra Gallach; Mireia Gil; Eloisa Jantus Lewintre; Eugenio Palomares; Carlos Camps
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
Carlos Camps; Vega Iranzo; Cristina Caballero; Ana Blasco; María José Godes; María José Safont; Sergio Blasco; Gloria Mengual; Alfonso Berrocal; Rafael Sirera
Oncology outside hospital: a new experience for the benefit of longer survivors.
Rafael Sirera; Mireia Gil; Ana Blasco; Andrea Cabrera; María José Safont; Vega Iranzo; Diego Cayuela; Rafael Rosell; Carlos Camps
Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of María José Safont (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: María José Safont; Elena Sanmartín; Rafael Sirera; Cristina Caballero; Nieves Del Pozo; Sandra Gallach; Mireia Gil; Eloisa Jantus Lewintre; Eugenio Palomares; Carlos Camps
The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2011;13(6):396-400.
2011: Carlos Camps; Vega Iranzo; Cristina Caballero; Ana Blasco; María José Godes; María José Safont; Sergio Blasco; Gloria Mengual; Alfonso Berrocal; Rafael Sirera
Oncology outside hospital: a new experience for the benefit of longer survivors.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2011;13(4):249-53.
2008: Rafael Sirera; Mireia Gil; Ana Blasco; Andrea Cabrera; María José Safont; Vega Iranzo; Diego Cayuela; Rafael Rosell; Carlos Camps
Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;61(1):104-8.
2006: Carlos Camps; Rafael Sirera; Roy M Bremnes; Vanessa Ródenas; Ana Blasco; María José Safont; Javier Garde; Asuncion Juarez; Cristina Caballero; Jose Javier Sanchez; Miquel Taron; Rafael Rosell
Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.
Anticancer research 2006;26(6C):4905-9.
2006: Carlos Camps; Rafael Sirera; Roy M Bremnes; Javier Garde; María José Safont; Ana Blasco; Alfonso Berrocal; José Javier Sánchez; Consuelo Calabuig; Miguel Martorell
Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.
Lung cancer (Amsterdam, Netherlands) 2006;52(3):343-7.
2005: Carlos Camps; Rafael Sirera; Roy M Bremnes; Ana Blasco; Eva Sancho; Pilar Bayo Zaera; María José Safont; José Javier Sánchez; Miquel Tarón; Rafael Rosell
Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2005;50(3):339-46.
2005: Carlos Camps; Cristina Caballero; Ana Blasco; María José Safont; Alfonso Berrocal; Javier Garde; Asunción Juarez; Rafael Sirera; Roy M Bremnes
Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.
Anticancer research 2005;25(6C):4611-4.